
### [DOID:1037](http://purl.obolibrary.org/obo/DOID_1037)
**Label:** lymphoblastic leukemia

**Subclasses:** [DOID:9952](http://purl.obolibrary.org/obo/DOID_9952) (acute lymphocytic leukemia), [DOID:1040](http://purl.obolibrary.org/obo/DOID_1040) (chronic lymphocytic leukemia), 

**Corr. equiv. classes:** [OMIM:613067](http://purl.obolibrary.org/obo/OMIM_613067), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [OMIM:613065](http://purl.obolibrary.org/obo/OMIM_613065), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), [OMIM:247640](http://purl.obolibrary.org/obo/OMIM_247640), 

**Class expressions from DL-Learner:**

- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0005523](http://purl.obolibrary.org/obo/HP_0005523) (Lymphoproliferative disorder))) 51.52%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0005508](http://purl.obolibrary.org/obo/HP_0005508) (Monoclonal immunoglobulin M proteinemia))) 51.52%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000024](http://purl.obolibrary.org/obo/HP_0000024) (Prostatitis))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000023](http://purl.obolibrary.org/obo/HP_0000023) (Inguinal hernia))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 48.33%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 48.33%


